ES2103991T3 - Glicosaminoglicanos semisinteticos que contienen acido alfa-l-galacturonico sustituido con radicales nucleofilos en posicion 3. - Google Patents

Glicosaminoglicanos semisinteticos que contienen acido alfa-l-galacturonico sustituido con radicales nucleofilos en posicion 3.

Info

Publication number
ES2103991T3
ES2103991T3 ES93103847T ES93103847T ES2103991T3 ES 2103991 T3 ES2103991 T3 ES 2103991T3 ES 93103847 T ES93103847 T ES 93103847T ES 93103847 T ES93103847 T ES 93103847T ES 2103991 T3 ES2103991 T3 ES 2103991T3
Authority
ES
Spain
Prior art keywords
semi
synthetic
galacturonic acid
acid substituted
glycosaminoglyces
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93103847T
Other languages
English (en)
Inventor
Silvano Piani
Egidio Marchi
Gianfranco Tamagnone
Fabrizio Ungarelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfa Wasserman SpA
Original Assignee
Alfa Wasserman SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wasserman SpA filed Critical Alfa Wasserman SpA
Application granted granted Critical
Publication of ES2103991T3 publication Critical patent/ES2103991T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

SE DESCRIBE LA SINTESIS DE NUEVOS GLICOSAMINOGLICANOS SEMISINTETICOS EN QUE UNA DE LAS UNIDADES SACARIDAS CARACTERISTICA DE LOS GLICOSAMINOGLICANOS CON UNA ESTRUCTURA DE HEPARINA O HEPARANO, Y DE MANERA MAS ESPECIFICA LA DE ACIDO DE -L-IDURONIC-2-O-SULFATO, HA PASADO POR UNA MODIFICACION ESTRUCTURAL, DE MANERA TOTAL O EN PARTE, TRANSFORMANDOSE EN UN ACIDO -L-GALACTURONICO SUSTITUIDO POR RADICALES NUCLEOFILICOS EN LA POSICION 3. ESTOS NUEVOS GLICOSAMINOGLICANOS SEMISINTETICOS DE LA FORMULA GENERAL (IV) PRESENTAN BUENAS PROPIEDADES FARMACEUTICAS EN CUANTO A QUE SE PUEDEN ABSORBER ORALMENTE Y TIENEN UNA BUENA ACTIVIDAD ANTITROMBOTICA ACOMPAÑADA DE UN BAJO RIESGO A QUE SE PRODUZCAN HEMORRAGIAS Y UNA ACTIVIDAD ANTICOAGULANTE REDUCIDA.
ES93103847T 1992-04-17 1993-03-10 Glicosaminoglicanos semisinteticos que contienen acido alfa-l-galacturonico sustituido con radicales nucleofilos en posicion 3. Expired - Lifetime ES2103991T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO920140A IT1260136B (it) 1992-04-17 1992-04-17 Glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonicosostituito con radicali nucleofili in posizione 3

Publications (1)

Publication Number Publication Date
ES2103991T3 true ES2103991T3 (es) 1997-10-01

Family

ID=11338174

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93103847T Expired - Lifetime ES2103991T3 (es) 1992-04-17 1993-03-10 Glicosaminoglicanos semisinteticos que contienen acido alfa-l-galacturonico sustituido con radicales nucleofilos en posicion 3.

Country Status (18)

Country Link
US (1) US5430132A (es)
EP (1) EP0565862B1 (es)
JP (1) JP2702377B2 (es)
KR (1) KR0171623B1 (es)
AT (1) ATE154615T1 (es)
AU (1) AU658499B2 (es)
CA (1) CA2093148C (es)
DE (1) DE69311618T2 (es)
DK (1) DK0565862T3 (es)
ES (1) ES2103991T3 (es)
FI (1) FI106555B (es)
GR (1) GR3024582T3 (es)
IL (1) IL105111A (es)
IT (1) IT1260136B (es)
NO (1) NO306305B1 (es)
NZ (1) NZ247197A (es)
TW (1) TW229213B (es)
ZA (1) ZA931799B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1260137B (it) * 1992-04-17 1996-03-28 Alfa Wassermann Spa Glicosaminoglicani semisintetici a struttura eparinica od eparanica modificati nella posizione 2 dell'acido alfa-l-iduronico-2-0-solfato
US5696100A (en) * 1992-12-22 1997-12-09 Glycomed Incorporated Method for controlling O-desulfation of heparin and compositions produced thereby
IT1264101B1 (it) * 1993-03-29 1996-09-10 Alfa Wassermann Spa Processo per la sintesi di glicosaminoglicani semisintetici a struttura eparinica od eparanica modificati nella posizione 2
IT1264102B1 (it) * 1993-03-29 1996-09-10 Alfa Wassermann Spa Processo per la sintesi di glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonico sostituito con radicali
US5583121A (en) * 1994-01-12 1996-12-10 Michigan State University Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
US6127347A (en) * 1994-01-12 2000-10-03 Univ Michigan Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
NO984143L (no) 1998-09-09 2000-03-10 Norsk Hydro As Ny prosess for å fremstille overflatemodifiserende stoffer
CA2377734A1 (en) * 1999-06-30 2001-01-11 Hamilton Civic Hospitals Research Development, Inc. Heparin compositions that inhibit clot associated coagulation factors
US7259152B2 (en) 2000-06-07 2007-08-21 Alfa Wasserman, Inc. Methods and compositions using sulodexide for the treatment of diabetic nephropathy
IL154771A0 (en) * 2000-09-08 2003-10-31 Hamilton Civic Hospitals Res Antithrombotic compositions
JP4828795B2 (ja) 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
ES2817779T3 (es) * 2010-01-19 2021-04-08 Momenta Pharmaceuticals Inc Evaluación de preparaciones de heparina
WO2012036152A1 (ja) * 2010-09-14 2012-03-22 国立大学法人 宮崎大学 高純度ヘパリンおよびその製造方法
US9068957B2 (en) 2011-02-21 2015-06-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
KR102468224B1 (ko) 2016-03-09 2022-11-17 가부시키가이샤 도우사 고가쿠 겐큐쇼 설페이트기 및/또는 포스페이트기를 갖는 당의 제조방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987223A (en) * 1981-12-23 1991-01-22 Choay S.A. Derivatives of the uronic acid
IT1234508B (it) * 1988-06-10 1992-05-19 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
DE3821271A1 (de) * 1988-06-23 1989-12-28 Solco Basel Ag Derivatisiertes heparin, verfahren zu dessen herstellung und arzneimittel, welches dieses enthaelt
IT1234826B (it) * 1989-01-30 1992-05-29 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
US5200523A (en) * 1990-10-10 1993-04-06 Monsanto Company Synthesis of nojirimycin derivatives

Also Published As

Publication number Publication date
EP0565862A3 (en) 1993-11-10
IL105111A (en) 1997-03-18
DE69311618T2 (de) 1997-12-11
KR930021651A (ko) 1993-11-22
US5430132A (en) 1995-07-04
NO931181L (no) 1993-10-18
FI931740A0 (fi) 1993-04-16
DE69311618D1 (de) 1997-07-24
EP0565862A2 (en) 1993-10-20
NO306305B1 (no) 1999-10-18
AU658499B2 (en) 1995-04-13
NO931181D0 (no) 1993-03-30
TW229213B (es) 1994-09-01
CA2093148C (en) 1999-01-26
ZA931799B (en) 1993-12-27
JP2702377B2 (ja) 1998-01-21
FI106555B (fi) 2001-02-28
JPH0616704A (ja) 1994-01-25
ITBO920140A1 (it) 1993-10-17
GR3024582T3 (en) 1997-12-31
ATE154615T1 (de) 1997-07-15
FI931740L (fi) 1993-10-18
EP0565862B1 (en) 1997-06-18
NZ247197A (en) 1995-02-24
AU3689693A (en) 1993-10-21
DK0565862T3 (da) 1997-12-15
KR0171623B1 (ko) 1999-02-01
ITBO920140A0 (it) 1992-04-17
IT1260136B (it) 1996-03-28
CA2093148A1 (en) 1993-10-18

Similar Documents

Publication Publication Date Title
ES2103991T3 (es) Glicosaminoglicanos semisinteticos que contienen acido alfa-l-galacturonico sustituido con radicales nucleofilos en posicion 3.
FI952048L (fi) Ruuansulatuksessa hajoamattomia rasvakoostumuksia, jotka sisältävät suhteellisen pieniä, kiinteitä, ruuansulatuksessa hajoamattomia hiukkasia öljyn passiivisen häviön säätelemiseksi
FI834872A0 (fi) Substituerade 4-aminoetylen-kromaner och -kromener, foerfaranden foer deras framstaellning och deraanvaendning som laekemedel
NO931184D0 (no) Halvsyntetiske glykosaminglykosaner med heparin- eller heparanstruktur
ES2176186T3 (es) Derivados de 2-imidazolina-5-ona y 2-imidazolina-5-tionas con propiedades fungicidas.
NO304885B1 (no) Nipectoin syrederivater som antitrombe forbindelser
IT8547938A0 (it) Dispersioni acquose di stabilizzanti contro gli effetti della luce
ES2110185T3 (es) Complejos de beta-lactama biciclica/parabeno.
DE69409758D1 (de) Herstellung von Alkyl-Tert-Alkylethern
ES2105382T3 (es) Procedimiento para la sintesis de glucosaminoglucanos semisinteticos que contienen acido alfa-l-galacturonico sustituido con radicales nucleofilos en posicion 3.
FI904947A7 (fi) Silikonaattia sisältävä zeoliitin vesisuspensio
DE69524064D1 (de) Indan-2-mercaptoacetylamid disulfidderivate als enkephalinase inhibitoren
FI904948A7 (fi) Stabiilit suksinoglykaania sisältävät zeoliitin vesisuspensiot
ES8401752A1 (es) Procedimiento para la preparacion de tioalcanoil-carnitinas.
ECSP951455A (es) Derivados de oxalilamino- benzofurano y benzotienilo
KR910002618U (ko) 유압식 엘리베이터의 버퍼빔 구조
KR910002619U (ko) 엘리베이터의 버퍼빔 구조
IT8420238A0 (it) Sospensioni stabili di zeoliti.
KR900019062U (ko) 냉장고의 도어힌지용 붓슈구조체
KR970032632U (ko) 자동차의 하이 빔 램프 에밍구조
ITUD910038U1 (it) Indicatore di accesso veicolare in monoblocco prefabbricato atto a seg nalare visivamente anche in precarie situazioni di foschie o nebbie l'
IT8353066V0 (it) Plafoniera particolarmente per l'illuminazione di carrozze ferro tramviarie
LV5219A3 (lv) Panemiens p-acetamidofenola dietiaminoacetata vai ta hlorhidrata iegusanai

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 565862

Country of ref document: ES